ArticlePloS one2013

Eukaryotic initiation factor 2α--a downstream effector of mammalian target of rapamycin--modulates DNA repair and cancer response to treatment.

Liron Tuval-Kochen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.